Summary Using an indirect immunohistochemical technique on paraffin sections, employing a polyclonal antibody to the acidic (placental) form of glutathione-S-transferase (GST), we have evaluated cytoplasmic and nuclear staining in a series of 67 cervical biopsies including normal non neoplastic tissue, immature squamous metaplasia, all grades of cervical intraepithelial neoplasia (CIN) and invasive carcinomas of keratinising and non-keratinising types. No differences in cytoplasmic staining between the varied lesions studied were seen. However, there were marked differences in nuclear staining. While normal non-neoplastic stratified squamous epithelium showed weak staining of the lower one-third of the epithelium only, in immature squamous metaplasia and in all grades of CIN there was intense nuclear staining in all layers of the epithelium. Invasive carcinomas showed generally less intense nuclear staining than CIN lesions. Endocervical cell nuclei also showed intense nuclear staining. These findings indicate that GST is of limited use as a marker of transformation in the human cervix uteri.
Neoplasia of the uterine cervix is a common disease which can be detected and treated at an early stage in its evolution. The importance of screening is likely to increase with the rising incidence of cervical intraepithelial neoplasia (CIN) and shift towards a younger population age group (Elliot et al., 1989) . However, cervical screening is a labour-intensive, time-consuming process and errors occasionally occur because of fatigue or because of the subjective nature of the interpretation of cervical cytology (Spriggs & Boddington, 1980) . A sensitive and specific marker of neoplastic cells might reduce the subjectivity of the task and perhaps be applied to an automated screening system (Sincock et al., 1983) .
Human papilloma virus (HPV) infection is thought to be involved in the development of many, if not all, cases of cervical neoplasia (Brescia et al., 1986; Young et al., 1989) , HPV types 6 and 11 being associated with benign lesions and 16 and 18 with invasive carcinoma (McCance, 1986) . However, the cellular events associated with neoplastic transformation are poorly understood. The study of the altered expression of a variety of products by neoplastic cells may help to elucidate the process of malignant transformation.
Previous studies have examined the expression of a number of potential markers of transformation, and studies on cytokeratin have been of particular interest amongst these (Morris et al., 1983; Fray et al., 1984) . While normal cervical stratified squamous epithelium expresses high molecular weight cytokeratins, all non-keratinising invasive squamous carcinomas and some cases of CIN3 express low-molecular weight cytokeratins as well as those of high molecular weight (Whittaker et al., 1989; Raju, 1988; Bobrow et al., 1986) . Using monoclonal antibody NCL-5D3, recognising cytokeratins 8, 18 and 19 (Angus et al., 1987) we have confirmed these observations (Angus et al., 1988 (Sterrett et al., 1987) . Some workers find demonstration of the number of nucleolar organiser regions in epithelial cells to be a useful marker of transformation (Egan et al., 1988) .
The cytosolic glutathione S-transferases (GST) are a group of enzymes involved in the conjugation of glutathione to a wide range of xenobiotics and as such are believed to be responsible for the detoxification of a variety of substances (Jakoby, 1978 (Jakoby, , 1980 . They are classified according to their iso-electric point into three groups, basic, acidic and neutral, which differ in their gene locus, amino acid sequence, and substrate specificity, and are immunologically distinct (Mannervik et al., 1985; Laisney et al., 1984; Jakoby, 1978) . The cellular role of the GSTs is a matter of speculation; a possible role in carcinogenesis has been suggested.
They may act by converting potential carcinogens to their active forms (Seidegard et al., 1986) . Additionally there is evidence that they may have a role in inactivation of some carcinogens (Clapper et al., 1987) . GSTs have also been implicated in the development of drug resistance in some tumours by inactivating chemotherapeutic agents. Evidence for this comes from work with drug resistant cell lines (Wang & Tew, 1985; Robson et al., 1987) and also studies of tumour biopsies which have suggested that those tumours which are generally resistant to chemotherapy, for example colonic carcinomas, have high levels of acidic GST, whilst those generally responsive, for example those of the head and neck, have low levels (Clapper et al., 1987) . Shiratori et al. (1987) demonstrated increased expression of acidic GST, both nuclear and cytoplasmic, in all grades of CIN as well as invasive lesions, compared with absence of expression in normal stratified squamous epithelium. This group used a rabbit polyclonal antibody for immunohistochemical evaluation of expression and they further demonstrated enhanced v-H-ras gene product in many lesions showing enhanced GST expression. Shiratori proposed that GST was a potentially useful marker for pre-neoplasia of the human cervix. The purpose of the present studies was to evaluate this hyopothesis using a polyclonal antibody raised in rabbits to GST purified from a human spleen.
Materials and methods

Cases
Neutral buffered formalin-fixed, paraffin wax-embedded tissue was retrieved from the files of Middlesbrough General Hospital. The material studied consisted of seven normal cervices from hysterectomy specimens, 11 colposcopic biopsies showing immature squamous metaplasia, seven each of CINI, CIN2 and CIN3 from colposcopic biopsy specimens and 28 invasive carcinomas, some of which were from cervical punch biopsies (n = 18) while others were from hysterectomy specimens (n = 10).
Routine diagnostic criteria were applied (Buckley et al., 1982) (Ludwig et al., 1981) .
Purification of glutathione S-transferase Acidic GST was obtained from the spleen of a patient with chronic lymphocytic leukaemia and purified using affinity chromatography and fast protein liquid chromatography (FPLC) on Mono Q. (Mannervik & Guthenberg, 1981; Habik & Jakoby, 1981) . The enzyme isolated in this way has similar substrate specificities, molecular weight on SDS-PAGE and iso-electric point as the human pi form isolated from placenta (manuscript in preparation).
Preparation of antiserum Polyclonal antiserum to the GST was raised in male New Zealand white rabbits. Protein (150-200 tg) was injected into the hind quarter intramuscularly on each occasion initially with Freund's complete adjuvant. Subsequent monthly injections used Freund's incomplete adjuvant. Antiserum specificity and titre were assessed using both an ELISA technique and immunoblotting. The antiserum cross-reacts with placental and platelet GST. No cross-reactions with basic and neutral forms of GST isolated from human liver, or with other cytosolic proteins, were seen at dilutions of 1 in 1,000 (ELISA, immunoblotting) and 1 in 100 (immunocytochemistry) (manuscript in preparation).
Immunohistochemical staining
The principles of the methods used have been described by Burns (1979) . Three jAm paraffin wax sections were cut from the tissue blocks and mounted on lysine coated slides. The sections were dried, dewaxed and rehydrated. After washing with water the sections were immersed in TRIS buffered saline for S min and then covered by normal swine serum diluted 1 in 5 with TRIS buffered saline. However, marked differences in nuclear staining between normal stratified squamous cervical epithelium, immature squamous metaplasia, CIN and invasive carcinoma were observed. Most of the normal cervices showed nuclear staining graded as + intensity of less than 25% of cells, mainly in the lower layers of the stratified squamous epithelium (Tables I and II, Figure 1) . In all grades of CIN, there was more intense nuclear staining of a greater proportion of the cells (Tables I and II) , and staining of nuclei in the upper epithelial layers was also noted (Figures 2-4) . Immature squamous metaplasia showed a nuclear staining pattern similar to that of CIN. Nuclear staining in the invasive carcinomas was variable, but in general was less intense than in CIN, and in most cases less than 50% of the cells showed nuclear staining. No differences in nuclear staining pattern between non-keratinising and keratinising squamous carcinomas were found (Tables I and II) . The koilocytes present in many of the cases of CIN showed both cytoplasmic and The numbers shown indicate the numbers of cases falling into each category.
nuclear staining but this did not appear to differ in intensity or distribution from that seen in the non-koilocytotic cells.
Where endocervical epithelium was present, all cases showed nuclear staining ( Figure 5 ).
Discussion
Although we have found an association between the development of cervical neoplasia and expression of GST, our results differ from those of Shiratori et al. (1987) , who found an increase in both cytoplasmic and nuclear expression of GST with increasing severity of neoplasia from CIN1 to invasive carcinoma. In contrast, we found no differences in cytoplasmic staining, while nuclear staining was increased in all grades of CIN, but not in invasive carcinomas. Unlike these workers, we found no association between koilocytosis and expression of GST.
The differences in these results may be due to either the specificity of the primary antibody or the technical methods used. Although both primary antibodies were shown to be specific for acidic GST, Shiratori et al. (1987) used antiserum raised to GST of placental origin, whereas our antiserum was raised to GST derived from the spleen of a patient with chronic lymphocytic leukaemia. Thus there may be minor differences in the specificities of the antibodies which could affect binding at some sites. Furthermore, while our tissues were fixed in formalin, most of the specimens used by Shiratori et al. (1987) The role of GST in neoplastic transformation is not clear. Our findings do not suggest that it is related to cell proliferation, since expression was less in the invasive carcinomas than in the cases of CIN. Furthermore, GST expression was often maximal in the upper epithelial layers in cases of CIN, including CIN1, whereas proliferation would be expected to be greatest in the lower layers.
GST may be involved in the process of carcinogenesis, perhaps by carcinogen activation or inactivation (Wang & Tew, 1985; Robson et al., 1987; Seidegard et al., 1986) or in response to viral infection. This function may become obsolete once malignant transformation has occurred, explaining the decreased nuclear expression which we found in invasive carcinomas.
Our studies indicate that GST would be of limited use as a marker of cervical neoplasia in cervical cytology screening by either conventional or automated methods. The increased nuclear expression of GST was consistent, in that the intenincreasedĩn al bu on:aeo;CN oee, enoeria A. incraseds inells but onecasualosbe ofCNtowiever,y endocervical cells visually in a cervical smear preparation, but an automated process would require a second marker. For example, nuclear GST positive cells could be evaluated for DNA content (Millet et al., 1982) , or endocervical cells discounted by staining for an antibody specific for simple epithelium. The expression of GST by immature squamous metaplasia is particularly disappointing as this lesion may be mistaken for CIN on both cytology and histology.
A Although GST may be of use in diagnostic cytology, it seems likely that more specific markers of transformation, such as oncogene or tumour suppressor gene nuclei acid or protein (Spandidos & Anderson, 1989 ) may prove to be more valuable in this area. As well as immunohistochemistry, techniques such as in situ hybridisation, applied successfully to detection of viral nucleic acid in cervical lesions (Burns et al., 1987) have potential use.
In conclusion, GST shows lack of specificity for CIN and possibly also lack of sensitivity for invasive carcinoma and therefore is of little use as a marker of transformation in the human cervix uteri.
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